INAB (IN8bio, Inc.) Stock Market Reviews

crown

search

Read and share opinions on INAB (IN8bio, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

INAB

IN8bio, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
Oct 29, 2025
IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial
Jun 9, 2025
IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products
May 12, 2025
IN8bio to Present Clinical and Preclinical Data from Gamma-Delta T Cell Platform at Upcoming Scientific Conferences
Apr 29, 2025
IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
Mar 31, 2025
IN8bio to Participate at the 11th Annual Immuno-Oncology 360° Conference 2025
Mar 18, 2025
INAB: Introducing INB-600, A γδ T Cell Engager Platform
Mar 17, 2025
IN8bio to Present at the TD Cowen 45th Annual Health Care Conference
Feb 26, 2025
IN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Feb 24, 2025
INAB: Continued Survival in INB-100 Trial
Feb 19, 2025
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
Feb 14, 2025

Reviews